Embryonic platelet-activating factor: an indicator of embryo viability

Area of Science:

• Reproductive biology
• Biochemistry
• In vitro fertilization (IVF)

Background:

• A critical need exists for reliable biomarkers to assess embryonic viability and predict pregnancy outcomes.
• Platelet-activating factor (PAF) production by human embryos has shown a relationship with their implantation and pregnancy potential.

Purpose of the Study:

• To investigate the correlation between Platelet-activating factor (PAF) levels in human embryo conditioned culture media and subsequent pregnancy outcomes.
• To determine if PAF can serve as a predictive biomarker for embryo viability in IVF.

Main Methods:

• Conditioned embryo culture media were collected from human embryos on day 3 of in vitro fertilization (IVF).
• Platelet-activating factor (PAF) levels were quantified in the collected media.
• PAF levels were statistically correlated with observed pregnancy outcomes.

Main Results:

• A significant difference in PAF levels was observed between pregnant (92.1 ± 9.5 pmol/l/embryo) and non-pregnant (52.5 ± 16.6 pmol/l/embryo) groups (P < 0.05).
• Embryos from patients with higher PAF levels demonstrated significantly higher pregnancy rates (medium: 85%, high: 89%) compared to those with low PAF levels (≤ 5 pmol/l/embryo: 60%).
• A receiver-operator characteristic curve analysis suggested a cut-off PAF level of 45 pmol/l/embryo for predicting pregnancy.

Conclusions:

• Platelet-activating factor (PAF) levels in human embryo conditioned culture media are significantly correlated with pregnancy outcomes.
• Increasing embryonic PAF levels correspond to a higher likelihood of successful pregnancy.
• PAF demonstrates potential as a valuable biomarker for assessing embryo viability and predicting pregnancy success in assisted reproductive technologies.